Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-23-000169
Filing Date
2023-02-14
Accepted
2023-02-14 16:14:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss1758571_sc13ga.htm SC 13G/A 38419
  Complete submission text file 0000947871-23-000169.txt   39934
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED CAPITAL LLC (Filed by) CIK: 0001157524 (see all company filings)

EIN.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Subject) CIK: 0001833141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-93441 | Film No.: 23629455
SIC: 2834 Pharmaceutical Preparations